Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD‑like receptor protein 3 inflammatory corpuscle

Gu,Chunmei; Liu,Shumei; Wang,Hongyue; Dou,Haichuan

doi:10.3892/ijmm.2019.4163

Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD‑like receptor protein 3 inflammatory corpuscle

Authors:
- Chunmei Gu
- Shumei Liu
- Hongyue Wang
- Haichuan Dou
View Affiliations

Affiliations: Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Endocrinology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: April 11, 2019 https://doi.org/10.3892/ijmm.2019.4163
Pages: 2440-2450
Copyright: © Gu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammatory response serves an important role in diabetic nephropathy (DN); however, the mechanism of inflammatory response results in renal damage is not yet clear. The aim of the present study was to investigate the role of the thioredoxin interacting protein (TXNIP)/NOD‑like receptor protein 3 (NLRP3) axis‑mediated activation of NLRP3 inflammasome in DN. A diabetic rat model was induced by streptozotocin injection. Hematoxylin and eosin (H&E) staining and streptavidin‑peroxidase staining were then used to examine the kidney tissue morphology, and TXNIP and NLRP3 protein expression levels, respectively. Furthermore, RNA interference technology was applied to silence the TXNIP gene. TXNIP and NLRP3 inflammasome activation‑associated proteins and mRNAs were detected by western blot analysis and RT‑qPCR, respectively. Enzyme‑linked immunosorbent assay was also used to examine interleukin (IL)‑1 and IL‑18 expression, while flow cytometry was performed to detect reactive oxygen species production. The data revealed that TXNIP and NLRP3 were overexpressed in kidney tissue of DN rats, and the level of antioxidant genes was downregulated. It was also observed that glucose promoted TXNIP expression and activation of NLRP3 inflammasome in a time‑dependent and dose‑dependent manner, therefore promoting inflammatory responses. Silencing of TXNIP gene resulted in the downregulation of NLRP3 inflammasome activation, and inhibited the expression levels of IL‑1 and IL‑18 in a high‑glucose environment. Furthermore, low expression of TXNIP promoted the levels of antioxidant genes and reduced the ROS levels. Taken together, the high‑glucose environment was able to upregulated the level of inflammatory factors by promoting the expression of TXNIP and the activation of NLRP3 inflammasome, consequently participating in DN.

View Figures

View References

1	Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
2	Duran-Salgado MB and Rubio-Guerra AF: Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398. 2014. View Article : Google Scholar : PubMed/NCBI
3	Beisswenger PJ, Drummond KS, Nelson RG, Howell SK, Szwergold BS and Mauer M: Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes. 54:3274–3281. 2005. View Article : Google Scholar : PubMed/NCBI
4	Shahzad K, Bock F, Dong W, Wang H, Kopf S, Kohli S, Al-Dabet MM, Ranjan S, Wolter J, Wacker C, et al: Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 87:74–84. 2015. View Article : Google Scholar :
5	Sun B, Wang X, Ji Z, Li R and Xia T: NLRP3 inflammasome activation induced by engineered nanomaterials. Small. 9:1595–1607. 2013. View Article : Google Scholar
6	Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T and Rouis M: NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 4:296–307. 2015. View Article : Google Scholar : PubMed/NCBI
7	Granata S, Masola V, Zoratti E, Scupoli MT, Baruzzi A, Messa M, Sallustio F, Gesualdo L, Lupo A and Zaza G: NLRP3 inflammasome activation in dialyzed chronic kidney disease patients. PLoS One. 10:e01222722015. View Article : Google Scholar : PubMed/NCBI
8	Hutton HL, Ooi JD, Holdsworth SR and Kitching AR: The NLRP3 inflammasome in kidney disease and autoimmunity. Nephrology (Carlton). 21:736–744. 2016. View Article : Google Scholar
9	Ogata FT, Batista WL, Sartori A, Gesteira TF, Masutani H, Arai RJ, Yodoi J, Stern A and Monteiro HP: Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization. PLoS One. 8:e845882013. View Article : Google Scholar :
10	Mohamed IN, Hafez SS, Fairaq A, Ergul A, Imig JD and El-Remessy AB: Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia. 57:413–423. 2014. View Article : Google Scholar :
11	Sonne SB, Perrett RM, Nielsen JE, Baxter MA, Kristensen DM, Leffers H, Hanley NA and Rajpert-De-Meyts E: Analysis of SOX2 expression in developing human testis and germ cell neoplasia. Int J Dev Biol. 54:755–760. 2010. View Article : Google Scholar
12	Lim J, Goriely A, Turner GD, Ewen KA, Jacobsen GK, Graem N, Wilkie AO and Rajpert-De Meyts E: OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol. 224:473–483. 2011. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA and Schauer PR: Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 9:7–14. 2013. View Article : Google Scholar
15	Lenzen S: The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 51:216–226. 2008. View Article : Google Scholar
16	Elias D, Prigozin H, Polak N, Rapoport M, Lohse AW and Cohen IR: Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes. 43:992–998. 1994. View Article : Google Scholar : PubMed/NCBI
17	Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF and Haffner SM: Metabolic and inflammation variable clusters and prediction of type 2 diabetes: Factor analysis using directly measured insulin sensitivity. Diabetes. 53:1773–1781. 2004. View Article : Google Scholar : PubMed/NCBI
18	Wada J and Makino H: Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 124:139–152. 2013. View Article : Google Scholar
19	Elsherbiny NM, Al-Gayyar MM, Abd El and Galil KH: Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis. Life Sci. 143:8–17. 2015. View Article : Google Scholar : PubMed/NCBI
20	Gonul Y, Kazandi S, Kocak A, Ahsen A, Bal A, Karavelioglu A, Hazman O, Turamanlar O, Kokulu S and Yuksel S: Interleukin-18 binding protein pretreatment attenuates kidney injury induced by hepatic ischemia reperfusion. Am J Med Sci. 352:200–207. 2016. View Article : Google Scholar : PubMed/NCBI
21	Zhen J, Zhang L, Pan J, Ma S, Yu X, Li X, Chen S and Du W: AIM2 mediates inflammation-associated renal damage in hepatitis B virus-associated glomerulonephritis by regulating caspase-1, IL-1beta, and IL-18. Mediators Inflamm. 2014:1908602014. View Article : Google Scholar
22	Lin YC, Huang DY, Wang JS, Lin YL, Hsieh SL, Huang KC and Lin W: Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization. J Leukoc Biol. 97:825–835. 2015. View Article : Google Scholar : PubMed/NCBI
23	Karmakar M, Katsnelson M, Malak HA, Greene NG, Howell SJ, Hise AG, Camilli A, Kadioglu A, Dubyak GR and Pearlman E: Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux. J Immunol. 194:1763–1775. 2015. View Article : Google Scholar : PubMed/NCBI
24	Chen K, Zhang J, Zhang W, Zhang J, Yang J, Li K and He Y: ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy. Int J Biochem Cell Biol. 45:932–943. 2013. View Article : Google Scholar : PubMed/NCBI
25	Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G and Hornung V: Cutting edge: Reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol. 187:613–617. 2011. View Article : Google Scholar : PubMed/NCBI
26	Huang C, Zhang Y, Kelly DJ, Tan CY, Gill A, Cheng D, Braet F, Park JS, Sue CM, Pollock CA and Chen XM: Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway. Sci Rep. 6:291962016. View Article : Google Scholar : PubMed/NCBI
27	Samra YA, Said HS, Elsherbiny NM, Liou GI, El-Shishtawy MM and Eissa LA: Cepharanthine and piperine ameliorate diabetic nephropathy in rats: Role of NF-kappaB and NLRP3 inflammasome. Life Sci. 157:187–199. 2016. View Article : Google Scholar : PubMed/NCBI
28	Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia Jda S, Ulevitch RJ, Hoffman HM and McKay DB: An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 185:6277–6285. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kim HJ, Lee DW, Ravichandran K, O Keys D, Akcay A, Nguyen Q, He Z, Jani A, Ljubanovic D and Edelstein CL: NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury. J Pharmacol Exp Ther. 346:465–472. 2013. View Article : Google Scholar : PubMed/NCBI
30	Zhang W, Zhao S, Li Y, Peng G and Han P: Acute blood glucose fluctuation induces myocardial apoptosis through oxidative stress and nuclear factor-kB activation. Cardiology. 124:11–17. 2013. View Article : Google Scholar
31	Feng H, Gu J, Gou F, Huang W, Gao C, Chen G, Long Y, Zhou X, Yang M, Liu S, et al: High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells. J Diabetes Res. 2016:69731752016. View Article : Google Scholar : PubMed/NCBI
32	Chen W, Zhao M, Zhao S, Lu Q, Ni L, Zou C, Lu L, Xu X, Guan H, Zheng Z and Qiu Q: Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: A novel inhibitory effect of minocycline. Inflamm Res. 66:157–166. 2017. View Article : Google Scholar
33	Devi TS, Hosoya K, Terasaki T and Singh LP: Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: Implications for diabetic retinopathy. Exp Cell Res. 319:1001–1012. 2013. View Article : Google Scholar : PubMed/NCBI
34	Han Y, Xu X, Tang C, Gao P, Chen X, Xiong X, Yang M, Yang S, Zhu X, Yuan S, et al: Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol. 16:32–46. 2018. View Article : Google Scholar : PubMed/NCBI
35	Zhou R, Tardivel A, Thorens B, Choi I and Tschopp J: Thioredoxin-interacting protein links oxidative stress to inflam-masome activation. Nat Immunol. 11:136–140. 2010. View Article : Google Scholar
36	Li W, Wu Z, Ma Q, Liu J, Xu Q, Han L, Duan W, Lv Y, Wang F, Reindl KM and Wu E: Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. Curr Cancer Drug Targets. 14:348–356. 2014. View Article : Google Scholar : PubMed/NCBI
37	Li J, Yue Z, Xiong W, Sun P, You K and Wang J: TXNIP over-expression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK pathway activation. Oncol Rep. 37:3369–3376. 2017. View Article : Google Scholar : PubMed/NCBI
38	Chang A, Ko K and Clark MR: The emerging role of the inflammasome in kidney diseases. Curr Opin Nephrol Hypertens. 23:204–210. 2014. View Article : Google Scholar : PubMed/NCBI
39	Shirasuna K, Takano H, Seno K, Ohtsu A, Karasawa T, Takahashi M, Ohkuchi A, Suzuki H, Matsubara S, Iwata H and Kuwayama T: Palmitic acid induces interleukin-1beta secretion via NLRP3 inflammasomes and inflammatory responses through ROS production in human placental cells. J Reprod Immunol. 116:104–112. 2016. View Article : Google Scholar : PubMed/NCBI
40	Xia M, Abais JM, Koka S, Meng N, Gehr TW, Boini KM and Li PL: Characterization and activation of NLRP3 inflammasomes in the renal medulla in mice. Kidney Blood Press Res. 41:208–221. 2016. View Article : Google Scholar : PubMed/NCBI